Modulating NND3 Gene Expression to Reduce Tobacco Alkaloid Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reducing tobacco-specific nitrosamines (TSNAs) in tobacco plants are costly and complex, and there is a need for a more effective and inexpensive molecular-based approach to lower nornicotine levels, which are precursors to carcinogenic TSNAs.
Innovation Solution
Identification of a novel nicotine N-demethylase gene, NND3, in Nicotiana tabacum, which has a distinct expression profile compared to other nicotine demethylase genes, allowing for reduced nicotine conversion to nornicotine, thereby decreasing TSNAs levels when its expression is modulated, either through mutations or combined with other nicotine demethylase genes like CYP82E4 and CYP82E5.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional methods (microwaving, trapping sinks, controlled environment curing) are used to reduce TSNAs, then TSNAs levels are reduced, but production cost and process complexity increase considerably
Solution Approach 1:
The invention extracts and targets the specific enzymatic step (nicotine demethylase activity) that converts nicotine to nornicotine, the precursor to TSNAs. By using RNAi technology to selectively suppress this enzyme's expression, the method removes the root cause of TSNA formation without requiring complex post-processing steps like microwaving or trapping sinks, thereby reducing both TSNAs and process complexity
Solution Approach 2:
The invention replaces mechanical/physical methods (microwaving, airflow control, trapping sinks) with a molecular biological approach (RNAi gene silencing). This substitution eliminates the need for expensive equipment and complex process controls while achieving TSNA reduction through targeted molecular intervention in the plant's metabolic pathway
2Object-affected harmful factors
If conventional methods (micrawving, trapping sinks, controlled environment curing) are used to reduce TSNAs, then TSNAs levels are reduced, but production time and cost increase
Solution Approach 1:
The invention performs preliminary action by suppressing the nicotine demethylase gene expression during plant growth and development, before the curing process occurs. This preventive approach ensures that nornicotine levels are already reduced prior to curing, eliminating the need for time-consuming post-curing treatments and thereby maintaining production efficiency while reducing TSNAs
Solution Approach 2:
By extracting and targeting the specific enzymatic step (nicotine demethylase) that leads to TSNA precursor formation, the method eliminates the need for multiple sequential processing steps (microwaving, trapping, controlled curing), thereby streamlining the production process and maintaining productivity while achieving TSNA reduction
3Object-affected harmful factors
If nicotine demethylase activity is reduced, then nornicotine levels and TSNAs are reduced, but the conversion of nicotine to nornicotine is affected
Solution Approach 1:
The invention applies local quality by selectively targeting only the nicotine demethylase enzyme responsible for converting nicotine to nornicotine, while leaving other alkaloid pathways and plant functions intact. This localized intervention changes the composition specifically at the nicotine-nornicotine conversion step without disrupting the overall plant metabolism or other alkaloid profiles, thus reducing nornicotine while maintaining plant stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modulation of NND3 expression leads to reduced levels of nornicotine and its metabolites, such as NNN, in tobacco smoke, potentially lowering the carcinogenic potential of tobacco products and reducing human exposure to these harmful compounds.
Implementation Method 1
The primary biochemical mechanism of NNN formation is the N-nitrosation of nornicotine, an alkaloid produced through the N-demethylation of nicotine by the enzyme nicotine N-demethylase
Implementation Method 2
The primary biochemical mechanism of NNN formation is the N-nitrosation of nornicotine
Implementation Method 3
The reduction of nitrates to nitrites is believed to occur by the action of bacteria on the surface of the leaf under anaerobic conditions
Data Source
AI summary
The present invention relates to a mutant, non-naturally occurring or transgenic tobacco plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a functional nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:2; (ii) a polypeptide encoded by the polynucleotide set forth in (i); (iii) a polypeptide comprising, consisting or consisting essentially of a sequence encoding a nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:3; or (iv) a construct, vector or expression vector comprising the isolated polynucleotide set forth in (i), and wherein the expression or activity of said nicotine demethylase is reduced as compared to a control tobacco plant cell in which the expression or activity of said nicotine demethylase has not been reduced.